Three batches of Gentacan have been recalled following importation by Wadi Altanfeez Commercial Establishment
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Gentacan injection Gentamicine Unregistered IS-340 Shivam Enterprises GTA24004 GTA24002
التصنيف
ملف
التاريخ
2025-12-18
اسم المستحضر
Gentacan
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The SFDA has issued a recall for three batches of Gentacan injection following non-compliance with the requirements stipulated in the Executive Regulations of the Pharmaceutical Establishments System.
التوصيات
For healthcare professionals: Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.